 |
|
|
[ send your article ] ArticlesMore articles: [newest], [05], [04], [03], [02], [01] Researchers at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark), partially supported by Varian Medical Systems (NYSE: VAR), have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. [ read full article ] The new American Cancer Society (ACS) issued updated screening guidelines provide detailed advice on the kind of information that should be discussed regarding the pros and cons of the screening tests. [ read full article ] Basically, localized prostate cancer treatment falls into one of two general categories: (a) kill or surgically prostate removal (and prostate cancer) cells in the patient or (b) monitor (by active surveillance) the patient until he needs hormone therapy (with the hope that he never does). [ read full article ] According to a science advisory published in Circulation: Journal of the American Heart Association, (AHA) androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death. [ read full article ] According to a group of researchers at Queen’s University in Kingston, Ontario, a very low dose of nitroglycerin may be able to delay the progression of prostate cancer in men with a rising PSA after standard first-line treatment with radiotherapy or surgery. [ read full article ] One of the most concerning problem for patients in the treatment of prostate cancer is erectile dysfunction. The inconsistent evaluation of sexual function (SF) and limited follow-up data request additional study to clarify the rate and timing of erectile dysfunction after external beam radiotherapy (EBRT) for prostate cancer. [ read full article ] A recent study at Department of Urology and Andrology, CHU Reims, Reims, France, aimed to report on technical incidents and early and late complications occurring in high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. [ read full article ] A new study at Sutter Roseville Medical Center, Roseville, CA, USA, aimed to evaluate the percentages of men with and without changes in sexual function from the beginning to end of radiation therapy. The study also evaluated differences in demographic and clinical characteristics, ... [ read full article ] A recent study at Memorial Sloan-Kettering Cancer Center revealed that inexperienced surgeons treat many prostate cancer patients in United States. This lack of high-volume experience induces increased complications such as incontinence and impotence, and possible cancer recurrence. [ read full article ] The updated NCCN clinical guidelines for prostate cancer now include an explicit recommendation for active surveillance (watchful waiting) and only active surveillance for many men diagnosed with prostate cancer. [ read full article ] More articles: [newest], [05], [04], [03], [02], [01] [ send your article ] NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|